1 Balmain A,Gray J,Ponder B.The genetics and genomics of cancer[J].Nat Genet,2003,33(Suppl):238-244. 2 Devarakonda S,Morgensztern D,Govindan R.Genomic alterations in lung adenocarcinoma[J].Lancet Oncol,2015,16(7):342-351. 3 Li J,Li WX,Bai C,et al.Particulate matter-induced epigenetic changes and lung cancer[J].Clin Respir J,2017,11(5):539-546. 4 Luo J,Solimini NL,Elledge SJ.Principles of cancer therapy:oncogene and non-oncogene addiction[J].Cell,2009,136(5):823-837. 5 Chang K,Elledge SJ,Hannon GJ.Lessons from Nature:microRNA-based shRNA libraries[J].Nat Methods,2006,3(9):707-714. 6 Mohr SE,Smith JA,Shamu CE,et,al.RNAi screening comes of age:improved techniques and complementary approaches[J].Nat Rev Mol Cell Biol,2014,15(9):591-600. 7 Sims D,Mendes-Pereira AM,Frankum J,et,al.High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing[J].Genome Biol,2011,12(10):104. 8 Sun T,Aceto N,Meerbrey KL,et al.Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase[J].Cell,2011,144(5):703-718. 9 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-32. 10 Gewinner C,Wang ZC,Richardson A,et al.Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling[J].Cancer Cell,2009,16(2):115-125. 11 Chen H,Li H,Chen Q.INPP4B overexpression suppresses migration,invasion and angiogenesis of human prostate cancer cells[J].Clin Exp Pharmacol Physiol,2017,44(6):700-708. 12 Budanov AV,Karin M.p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling[J].Cell,2008,134(3):451-460. 13 Izquierdo JM,Alcalde J,Carrascoso I,et al.Knockdown of T-cell intracellular antigens triggers cell proliferation,invasion and tumour growth[J].Biochem J,2011,435(2):337-344. 14 Papatriantafyllou M.Development:NUP210 takes cell fate decisions[J].Nat Rev Mol Cell Biol,2012,13(3):140. 15 Stebbing J,Filipovic A,Ellis IO,et al.LMTK3 expression in breast cancer:association with tumor phenotype and clinical outcome[J].Breast Cancer Res Treat,2012,132(2):537-544. |